[1]
F. M. Sta. Ines, J. J. Andal, R. M. Santiago, S. Sandoval, and D. Ang, “Programmed Death Ligand 1 (PD-L1) Expression and its Association with Clinicopathologic Profile in Patients with Non-Small Cell Lung Cancer in a Philippine Tertiary Medical Center”, Phil Journal Path, vol. 6, no. 1, pp. 8–17, Jun. 2021.